HUTCHMED Valuation
| H7T2 Stock | EUR 2.72 0.10 3.55% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. HUTCHMED LS 1 retains a regular Real Value of €2.52 per share. The prevalent price of the firm is €2.72. Our model calculates the value of HUTCHMED LS 1 from examining the firm fundamentals such as return on equity of -0.25, and Return On Asset of -0.19 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that HUTCHMED's price fluctuation is very risky at this time. Calculation of the real value of HUTCHMED LS 1 is based on 3 months time horizon. Increasing HUTCHMED's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the HUTCHMED stock is determined by what a typical buyer is willing to pay for full or partial control of HUTCHMED LS 1. Since HUTCHMED is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HUTCHMED Stock. However, HUTCHMED's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.72 | Real 2.52 | Hype 2.72 |
The real value of HUTCHMED Stock, also known as its intrinsic value, is the underlying worth of HUTCHMED LS 1 Company, which is reflected in its stock price. It is based on HUTCHMED's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of HUTCHMED's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of HUTCHMED LS 1 helps investors to forecast how HUTCHMED stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HUTCHMED more accurately as focusing exclusively on HUTCHMED's fundamentals will not take into account other important factors: HUTCHMED Total Value Analysis
HUTCHMED LS 1 is currently anticipated to have takeover price of 0 with market capitalization of 2.91 B, debt of 36.69 M, and cash on hands of 950.45 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HUTCHMED fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 2.91 B | 36.69 M | 950.45 M |
HUTCHMED Investor Information
About 45.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.24. HUTCHMED LS 1 had not issued any dividends in recent years. The entity had 10:1 split on the 30th of May 2019. Based on the measurements of operating efficiency obtained from HUTCHMED's historical financial statements, HUTCHMED LS 1 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.HUTCHMED Asset Utilization
One of the ways to look at asset utilization of HUTCHMED is to check how much profit was generated for every dollar of assets it reports. HUTCHMED retains a negative application of resources of -0.19 (percent), losing €0.001932 for each euro of resources held by the firm. Ineffective asset utilization attests that the company is being less efficient with each euro of resources it retains. Simply put, asset utilization of HUTCHMED LS 1 shows how unsuccessful it operates for each euro spent on its resources.HUTCHMED Ownership Allocation
HUTCHMED LS 1 has a total of 864.77 Million outstanding shares. Over half of HUTCHMED's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Accordingly, these institutions are subject to different rules and regulations than regular investors in HUTCHMED LS 1. Please watch out for any change in the institutional holdings of HUTCHMED as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.HUTCHMED Profitability Analysis
The company reported the revenue of 400.81 M. Net Loss for the year was (178.43 M) with loss before overhead, payroll, taxes, and interest of (201.19 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HUTCHMED's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HUTCHMED and how it compares across the competition.
About HUTCHMED Valuation
The stock valuation mechanism determines HUTCHMED's current worth on a weekly basis. Our valuation model uses a comparative analysis of HUTCHMED. We calculate exposure to HUTCHMED's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HUTCHMED's related companies.HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. HUTCHMED Limited was incorporated in 2000 and is headquartered in Central, Hong Kong. HUTCHMED operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1280 people.
8 Steps to conduct HUTCHMED's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HUTCHMED's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HUTCHMED's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HUTCHMED's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HUTCHMED's revenue streams: Identify HUTCHMED's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HUTCHMED's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HUTCHMED's growth potential: Evaluate HUTCHMED's management, business model, and growth potential.
- Determine HUTCHMED's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HUTCHMED's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED's price analysis, check to measure HUTCHMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED is operating at the current time. Most of HUTCHMED's value examination focuses on studying past and present price action to predict the probability of HUTCHMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED's price. Additionally, you may evaluate how the addition of HUTCHMED to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |